Severe Immune Thrombocytopenia after COVID-19 Vaccination: Two Case Reports and a Literature Review
- PMID: 35314552
- PMCID: PMC9177350
- DOI: 10.2169/internalmedicine.9177-21
Severe Immune Thrombocytopenia after COVID-19 Vaccination: Two Case Reports and a Literature Review
Abstract
We herein report two cases of coronavirus disease 2019 (COVID-19) vaccine-induced immune thrombocytopenia (ITP). A 69-year-old Japanese man developed severe thrombocytopenia after COVID-19 vaccination. He had oral bleeding and hemoptysis but no thrombotic symptoms. He improved rapidly with oral prednisolone therapy. A 34-year-old Japanese woman had generalized purpura after COVID-19 vaccination. Her platelet count improved rapidly after treatment with prednisolone and eltrombopag. The occurrence of two cases of ITP after COVID-19 vaccination at a single institution suggests that there could be more such undiagnosed cases, especially cases of mild secondary ITP.
Keywords: COVID-19; immune thrombocytopenia; vaccination.
Conflict of interest statement
Figures

Similar articles
-
Severe immune thrombocytopenia following COVID-19 vaccination (Moderna) and immune checkpoint inhibitor.Am J Emerg Med. 2022 Jun;56:395.e1-395.e3. doi: 10.1016/j.ajem.2022.03.030. Epub 2022 Mar 18. Am J Emerg Med. 2022. PMID: 35339338 Free PMC article.
-
Successful Treatment of Immune Thrombocytopenic Purpura with Intracranial Hemorrhaging and Duodenal Bleeding Following SARS-CoV-2 Vaccination.Intern Med. 2022 Jun 15;61(12):1891-1895. doi: 10.2169/internalmedicine.9199-21. Epub 2022 Apr 9. Intern Med. 2022. PMID: 35400701 Free PMC article.
-
[Immune thrombocytopenia after BNT162b2 mRNA COVID-19 vaccination].Rinsho Ketsueki. 2021;62(12):1688-1693. doi: 10.11406/rinketsu.62.1688. Rinsho Ketsueki. 2021. PMID: 35022338 Japanese.
-
Laboratory testing for suspected COVID-19 vaccine-induced (immune) thrombotic thrombocytopenia.Int J Lab Hematol. 2021 Aug;43(4):559-570. doi: 10.1111/ijlh.13629. Epub 2021 Jun 17. Int J Lab Hematol. 2021. PMID: 34138513 Free PMC article. Review.
-
Immune thrombocytopenia and COVID-19: Case report and review of literature.Lupus. 2021 Aug;30(9):1515-1521. doi: 10.1177/09612033211021161. Epub 2021 May 30. Lupus. 2021. PMID: 34053365 Review.
Cited by
-
Immune thrombocytopenic purpura secondary to COVID-19 vaccination: A systematic review.Eur J Haematol. 2023 Apr;110(4):335-353. doi: 10.1111/ejh.13917. Epub 2022 Dec 30. Eur J Haematol. 2023. PMID: 36562217 Free PMC article.
-
COVID-19-induced immune thrombocytopenia management approach: A case report and literature review.Clin Case Rep. 2024 Jun 14;12(6):e9070. doi: 10.1002/ccr3.9070. eCollection 2024 Jun. Clin Case Rep. 2024. PMID: 38883219 Free PMC article.
-
Immune Thrombocytopenia Following COVID-19 Vaccination.Intern Med. 2022 Sep 15;61(18):2827. doi: 10.2169/internalmedicine.0372-22. Epub 2022 Jul 14. Intern Med. 2022. PMID: 35831105 Free PMC article. No abstract available.
-
A Systematic Review of Vascular Injuries: A Review of Petechiae, Purpura, and Ecchymosis in Critical Situations Following COVID-19 Vaccination.Health Sci Rep. 2025 Mar 12;8(3):e70503. doi: 10.1002/hsr2.70503. eCollection 2025 Mar. Health Sci Rep. 2025. PMID: 40083673 Free PMC article. Review.
-
Internal Medicine Year in Review 2022.Intern Med. 2023 Dec 1;62(23):3431-3435. doi: 10.2169/internalmedicine.2266-23. Epub 2023 Jun 7. Intern Med. 2023. PMID: 37286505 Free PMC article.